Innovatus Provides $23MM Term Loan to Biodesix

Innovatus Capital Partners provided a $23 million term loan in a debt refinancing agreement with Biodesix, a molecular diagnostics company that develops and commercializes non-invasive, blood-based diagnostic tests for oncology.